• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者炎症和骨转换标志物与死亡率之间的关联

Associations Between Inflammatory and Bone Turnover Markers and Mortality in Hemodialysis Patients.

作者信息

Sircuța Alexandru Florin, Grosu Iulia Dana, Schiller Adalbert, Petrica Ligia, Ivan Viviana, Schiller Oana, Maralescu Felix-Mihai, Palamar Marcel, Mircea Monica-Nicoleta, Nișulescu Daniel, Goleț Ionuț, Bob Flaviu

机构信息

Department of Internal Medicine II-Nephrology University Clinic, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.

Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.

出版信息

Biomedicines. 2025 May 10;13(5):1163. doi: 10.3390/biomedicines13051163.

DOI:10.3390/biomedicines13051163
PMID:40426990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12109441/
Abstract

Chronic kidney disease-mineral and bone disorder (CKD-MBD) and systemic inflammation contribute to mortality in hemodialysis (HD) patients. The primary aim of this study was to determine whether specific CKD-MBD markers and inflammatory biomarkers are associated with increased mortality risk in HD patients. We conducted a retrospective cohort study on 63 stage 5D CKD patients undergoing maintenance HD. Serum intact parathyroid hormone (iPTH), soluble Klotho, calcium, phosphorus, 25(OH)D (25-hydroxyvitamin D), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), C-reactive protein (CRP), and interleukin-6 (IL-6) were analyzed. A Cox regression analysis assessed mortality predictors, and linear regression analysis evaluated CKD-MBD-inflammation correlations. Lower iPTH (<329.3 pg/mL) levels were the only significant mortality predictor ( = 0.042). Other CKD-MBD markers (calcium, phosphorus, 25(OH)D, VEGF, TGF-β) did not impact survival. Soluble Klotho correlated positively with IL-6 (r = 0.57, < 0.001), suggesting a compensatory inflammatory response. Our findings demonstrate that low iPTH levels and advanced age are independent predictors of mortality in hemodialysis patients. The positive association between soluble Klotho and IL-6 suggests a potential compensatory inflammatory response. These results highlight the need for further research to clarify underlying mechanisms and to explore novel therapeutic strategies.

摘要

慢性肾脏病-矿物质和骨异常(CKD-MBD)与全身炎症会导致血液透析(HD)患者死亡。本研究的主要目的是确定特定的CKD-MBD标志物和炎症生物标志物是否与HD患者死亡风险增加相关。我们对63例接受维持性血液透析的5D期CKD患者进行了一项回顾性队列研究。分析了血清完整甲状旁腺激素(iPTH)、可溶性klotho、钙、磷、25(OH)D(25-羟基维生素D)、转化生长因子-β(TGF-β)、血管内皮生长因子(VEGF)、C反应蛋白(CRP)和白细胞介素-6(IL-6)。Cox回归分析评估死亡预测因素,线性回归分析评估CKD-MBD与炎症的相关性。较低的iPTH(<329.3 pg/mL)水平是唯一显著的死亡预测因素(P = 0.042)。其他CKD-MBD标志物(钙、磷、25(OH)D、VEGF、TGF-β)对生存没有影响。可溶性klotho与IL-6呈正相关(r = 0.57,P < 0.001),提示存在代偿性炎症反应。我们的研究结果表明,低iPTH水平和高龄是血液透析患者死亡的独立预测因素。可溶性klotho与IL-6之间的正相关提示存在潜在的代偿性炎症反应。这些结果凸显了进一步研究以阐明潜在机制并探索新治疗策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/12109441/b46903032bef/biomedicines-13-01163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/12109441/b46903032bef/biomedicines-13-01163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/12109441/b46903032bef/biomedicines-13-01163-g001.jpg

相似文献

1
Associations Between Inflammatory and Bone Turnover Markers and Mortality in Hemodialysis Patients.血液透析患者炎症和骨转换标志物与死亡率之间的关联
Biomedicines. 2025 May 10;13(5):1163. doi: 10.3390/biomedicines13051163.
2
Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients.血清 25-羟维生素 D 水平与老年维持性血液透析患者的疲劳呈负相关。
Kidney Blood Press Res. 2023;48(1):231-240. doi: 10.1159/000529514. Epub 2023 Mar 7.
3
The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.慢性肾脏病患者尿肾损伤分子-1与血骨代谢标志物之间的关系
Clin Nephrol. 2020 Feb;93(2):65-76. doi: 10.5414/CN109763.
4
Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.维持性血液透析患者血浆中性粒细胞明胶酶相关载脂蛋白与 CKD-MBD 相关参数的关系。
J Bone Miner Metab. 2021 Nov;39(6):1058-1065. doi: 10.1007/s00774-021-01248-9. Epub 2021 Aug 15.
5
[Circulating bone turnover markers and their relationships in hemodialysis patients with vitamin D deficiency].[维生素D缺乏的血液透析患者循环骨转换标志物及其关系]
Wiad Lek. 2019;72(11 cz 2):2202-2209.
6
Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.慢性肾脏病-矿物质和骨异常(CKD-MBD)标志物与维持性血液透析患者全因死亡率的关联:一项在北京开展的队列研究
PLoS One. 2017 Jan 3;12(1):e0168537. doi: 10.1371/journal.pone.0168537. eCollection 2017.
7
Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder.成纤维细胞生长因子-23与慢性肾脏病-骨矿物质密度紊乱中生化标志物及骨密度的相关性
Cureus. 2023 Jan 17;15(1):e33879. doi: 10.7759/cureus.33879. eCollection 2023 Jan.
8
Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.血液透析患者的骨硬化蛋白、钙磷代谢紊乱、骨转换标志物和炎症的关系。
Int Urol Nephrol. 2019 Mar;51(3):519-526. doi: 10.1007/s11255-018-2050-3. Epub 2018 Dec 24.
9
High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients.高C末端成纤维细胞生长因子-23、完整甲状旁腺激素和白细胞介素-6作为维持性血液透析患者瓣膜钙化的决定因素
Int J Gen Med. 2022 Apr 20;15:4227-4236. doi: 10.2147/IJGM.S359168. eCollection 2022.
10
Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.中国晚期慢性肾脏病患者的碱性磷酸酶、甲状旁腺激素及骨转换标志物
Clin Lab. 2015;61(7):839-43. doi: 10.7754/clin.lab.2015.141101.

本文引用的文献

1
Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases.α-klotho抗衰老蛋白:疾病中的分子机制及治疗潜力
Mol Biomed. 2025 Mar 22;6(1):19. doi: 10.1186/s43556-025-00253-y.
2
Association of Gene Polymorphism and Serum Level of α Klotho Protein with Different Tumor Grades, Overall Survival and Cytokine Profile in Glioma Patients.胶质瘤患者中基因多态性和α-klotho蛋白血清水平与不同肿瘤分级、总生存期及细胞因子谱的相关性
Int J Mol Sci. 2025 Jan 2;26(1):330. doi: 10.3390/ijms26010330.
3
Hepatitis C Virus Infection in Hemodialysis Patients in the Era of Direct-Acting Antiviral Treatment: Observational Study and Narrative Review.
直接抗病毒治疗时代血液透析患者的丙型肝炎病毒感染:观察性研究与叙述性综述
Medicina (Kaunas). 2024 Dec 21;60(12):2093. doi: 10.3390/medicina60122093.
4
New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms.Klotho 在炎症和纤维化中的作用的新见解:分子和细胞机制。
Front Immunol. 2024 Sep 6;15:1454142. doi: 10.3389/fimmu.2024.1454142. eCollection 2024.
5
PTH may predict early mortality in incident patients on hemodialysis: results from a large cohort.甲状旁腺激素(PTH)可能预测血液透析初治患者的早期死亡率:一项大型队列研究结果
Int Urol Nephrol. 2025 Feb;57(2):545-551. doi: 10.1007/s11255-024-04188-1. Epub 2024 Sep 2.
6
The Relationship between Circulating Kidney Injury Molecule-1 and Cardiovascular Morbidity and Mortality in Hemodialysis Patients.血液透析患者循环肾损伤分子-1与心血管发病率和死亡率的关系
Biomedicines. 2024 Aug 20;12(8):1903. doi: 10.3390/biomedicines12081903.
7
Serum Levels of α-Klotho, Inflammation-Related Cytokines, and Mortality in Hemodialysis Patients.血液透析患者血清α-klotho水平、炎症相关细胞因子与死亡率
J Clin Med. 2022 Nov 2;11(21):6518. doi: 10.3390/jcm11216518.
8
Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018).海湾合作委员会国家血液透析患者甲状旁腺激素血清水平与死亡率:来自 DOPPS(2012-2018 年)的结果。
Kidney360. 2020 Aug 26;1(10):1083-1090. doi: 10.34067/KID.0000772020. eCollection 2020 Oct 29.
9
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.扩充性血液透析疗法通过调节 VEGF、TNF-α 和 AP-1 信号改善尿毒症引起的全身微炎症和内皮功能障碍。
Front Immunol. 2021 Nov 11;12:774052. doi: 10.3389/fimmu.2021.774052. eCollection 2021.
10
Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study.日本透析结果与实践模式研究中,成纤维细胞生长因子23与维持性血液透析患者死亡率的关系
Kidney Int Rep. 2020 Aug 20;5(11):1956-1964. doi: 10.1016/j.ekir.2020.08.013. eCollection 2020 Nov.